Shamim Ruff - Net Worth and Insider Trading

Shamim Ruff Net Worth

The estimated net worth of Shamim Ruff is at least $5 Million dollars as of 2024-05-26. Shamim Ruff is the SVP, Regulatory Affairs & Qual of Sarepta Therapeutics Inc and owns about 27,045 shares of Sarepta Therapeutics Inc (SRPT) stock worth over $3 Million. Shamim Ruff is also the Director of Reata Pharmaceuticals Inc and owns about 7,359 shares of Reata Pharmaceuticals Inc (RETA) stock worth over $1 Million. Details can be seen in Shamim Ruff's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Shamim Ruff has not made any transactions after 2023-07-28 and currently still holds the listed stock(s).

Transaction Summary of Shamim Ruff

To

Shamim Ruff Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Shamim Ruff owns 2 companies in total, including Sarepta Therapeutics Inc (SRPT) , and Reata Pharmaceuticals Inc (RETA) .

Click here to see the complete history of Shamim Ruff’s form 4 insider trades.

Insider Ownership Summary of Shamim Ruff

Ticker Comapny Transaction Date Type of Owner
SRPT Sarepta Therapeutics Inc 2017-11-06 SVP & Regulatory Affairs & Qual
RETA Reata Pharmaceuticals Inc 2023-09-26 director

Shamim Ruff Latest Holdings Summary

Shamim Ruff currently owns a total of 2 stocks. Among these stocks, Shamim Ruff owns 27,045 shares of Sarepta Therapeutics Inc (SRPT) as of November 6, 2017, with a value of $3 Million and a weighting of 72.47%. Shamim Ruff also owns 7,359 shares of Reata Pharmaceuticals Inc (RETA) as of July 28, 2023, with a value of $1 Million and a weighting of 27.53%.

Latest Holdings of Shamim Ruff

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SRPT Sarepta Therapeutics Inc 2017-11-06 27,045 123.46 3,338,976
RETA Reata Pharmaceuticals Inc 2023-07-28 7,359 172.36 1,268,397

Holding Weightings of Shamim Ruff


Shamim Ruff Form 4 Trading Tracker

According to the SEC Form 4 filings, Shamim Ruff has made a total of 0 transactions in Sarepta Therapeutics Inc (SRPT) over the past 5 years. The most-recent trade in Sarepta Therapeutics Inc is the sale of 10,000 shares on November 6, 2017, which brought Shamim Ruff around $550,000.

According to the SEC Form 4 filings, Shamim Ruff has made a total of 2 transactions in Reata Pharmaceuticals Inc (RETA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Reata Pharmaceuticals Inc is the sale of 8,235 shares on July 28, 2023, which brought Shamim Ruff around $1 Million.

Insider Trading History of Shamim Ruff

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Shamim Ruff Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Shamim Ruff Ownership Network

Ownership Network List of Shamim Ruff

No Data

Ownership Network Relation of Shamim Ruff


Shamim Ruff Owned Company Details

What does Sarepta Therapeutics Inc do?

Who are the key executives at Sarepta Therapeutics Inc?

Shamim Ruff is the SVP & Regulatory Affairs & Qual of Sarepta Therapeutics Inc. Other key executives at Sarepta Therapeutics Inc include Chief Tech Ops Officer Bilal Arif , Chief Financial Officer Ian Michael Estepan , and SVP & General Counsel Ryan Edward Brown .

Sarepta Therapeutics Inc (SRPT) Insider Trades Summary

Over the past 18 months, Shamim Ruff made no insider transaction in Sarepta Therapeutics Inc (SRPT). Other recent insider transactions involving Sarepta Therapeutics Inc (SRPT) include a net purchase of 68,532 shares made by Michael Andrew Chambers , a net sale of 30,000 shares made by Wigzell Hans Lennart Rudolf , and a net purchase of 50,000 shares made by Richard Barry .

In summary, during the past 3 months, insiders sold 27,731 shares of Sarepta Therapeutics Inc (SRPT) in total and bought 0 shares, with a net sale of 27,731 shares. During the past 18 months, 42,731 shares of Sarepta Therapeutics Inc (SRPT) were sold and 143,757 shares were bought by its insiders, resulting in a net purchase of 101,026 shares.

Sarepta Therapeutics Inc (SRPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sarepta Therapeutics Inc Insider Transactions

No Available Data

Shamim Ruff Mailing Address

Above is the net worth, insider trading, and ownership report for Shamim Ruff. You might contact Shamim Ruff via mailing address: 215 First Street, Suite 415, Cambridge Ma 02142.

Discussions on Shamim Ruff

No discussions yet.